首页 | 本学科首页   官方微博 | 高级检索  
     

低分割放疗联合吉非替尼治疗老年非小细胞肺癌疗效观察
引用本文:李小龙,党亚正,陆婉玲. 低分割放疗联合吉非替尼治疗老年非小细胞肺癌疗效观察[J]. 西部医学, 2013, 25(9): 1312-1315
作者姓名:李小龙  党亚正  陆婉玲
作者单位:解放军第323医院放疗中心,陕西西安,710054
基金项目:陕西省自然科学基金资助项目(项目编号:2012JM4008)
摘    要:目的探讨三维适形低分割放疗联合吉非替尼治疗老年非小细胞肺癌(NSCLC)的疗效及不良反应。方法对27例老年NSCLC患者实施低分割放疗联合吉非替尼治疗,分割方案:2.5Gy/d、5f/w,总剂量:35~55Gy;口服吉非替尼250mg,1次/日。结果 3个月近期有效率(CR+PR)66.7%,1年生存率63.0%;放射性肺炎发生率25.9%,放射性食管炎发生率29.6%,皮疹发生率37.0%,腹泻发生率22.2%。结论三维适形低分割放疗联合吉非替尼治疗安全有效,不良反应未见明显增加。

关 键 词:老年非小细胞肺癌  吉非替尼  低分割

Clinical efficacy of hypofractionated high-dose radiotherapy combined with gefitinib for the elderly non-small cell lung cancer
LI Xiao-long , DANG Ya-zheng , LU Wan-ling. Clinical efficacy of hypofractionated high-dose radiotherapy combined with gefitinib for the elderly non-small cell lung cancer[J]. , 2013, 25(9): 1312-1315
Authors:LI Xiao-long    DANG Ya-zheng    LU Wan-ling
Affiliation:(Xi' an Cancer Center, PLA 323 Hospital, Xi' an 710054)
Abstract:Objective To investigate the efficacy and toxicity of three-dimensional eonformal radiotherapy com- bined with gefitinib in elderly NSCLC. Methods 27 eases of elderly NSCLC patients were analyzed. Results The effica- cy rate was 66, 7%. 1-year survival rates were 63.0%, The incidence of radiation pneumonitis was 25.9%. The inci- dence of radiation esophagitis was 29.6%. The incidence of rash was 37.0% ,and the incidence of diarrhea was 22.2%. Conclusion The three-dimensional eonformal Hypofraetionated high-dose radiotherapy combined with gefitinib for elderly non-small cell lung cancer is safely and definitely,
Keywords:Elderly  Non-small cell lung cancer  Gefitinib  Hypofractionated high-dose
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号